View Cart  

FDA Lays Out Initial DMF Assessment Requirements Under GDUFA

The FDA has outlined the requirements that drugmakers submitting Type II active pharmaceutical ingredient (API) drug master files (DMF) must meet before the files are listed on the agency’s public website as available for reference to support an ANDA.

To View This Article:


Subscribe To Generic Line

Buy This Article Now

Add this article to your cart for $40.00